XEOS is delighted to invite you to an evening of science where we highlight the importance of molecular imaging in many aspects, with a focus on the OR. With speakers like Prof. Dr. Esposito, Dr. Fragoso and Dr. Scott, we will discuss the importance of intraoperative specimen imaging,... Learn More

West Chester, PA, May 21, 2024 -- Molecular Targeting Technologies, Inc. (MTTI), will update findings on both 177Lu-EBTATE clinical and 225Ac-EBTATE preclinical work during the 2024 SNMMI meeting in Toronto Convention Center (exhibition booth #1819) EBTATE®, an EvaThera platform therapeutic, is the first patented long-acting peptide targeted radiotherapeutic drug. It selectively targets... Learn More

CDL Nuclear Technologies is proud to announce our three innovative options to enhance cardiac care programs across diverse medical facilities. Understanding that each facility is at a different stage in Cardiac PET/CT development, CDL Nuclear offers tailored solutions to seamlessly integrate cutting-edge cardiac imaging technology. ... Learn More

LONDON and NEW YORK and TORONTO, May 16, 2024 (GLOBE NEWSWIRE) -- Claritas HealthTech Ltd, a company specializing in state-of-the-art image enhancement, reconstruction, and AI solutions for the medical industry, is pleased to announce the completion of iPETcertum™, its new software device for automated lesion detection, delineation, and automatic quantification of... Learn More

Spectrum Dynamics Medical, a leading innovator in digital SPECT imaging systems and Hermes Medical Solutions (HMS), a leader in molecular imaging software development are now partnering to offer an integrated vendor-neutral software solution for advanced processing, quantitative analysis and reviewing images from the Spectrum Dynamic's VERITON-CT scanner including access to... Learn More

License will support ITM’s efforts in preparing for the commercialization of its diagnostic and therapeutic radiopharmaceutical pipeline across the U.S. Garching / Munich and Princeton, NJ, February 1, 2024 - ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced... Learn More

A Novel Therapeutic Approach to Treatment using ITM-31 Garching/Munich, Munich and Münster, April 23, 2024 - The Departments of Neurosurgery and Nuclear Medicine at the University Hospital Münster, Helmholtz Munich, and ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that the first... Learn More

At a glance OPG’s nuclear power reactors are a critical source of important and life-saving medical isotopes for the world. The company is now... Learn More

LigandTracer monitors molecular interactions in real-time, right on your lab bench, with only a few preparatory steps and limited input. It is a flexible platform compatible with a large... Learn More

We're pleased to announce the launch of Alpha-Tocopheryl 2,3,5-Triiodobenzoate iodinated oil for building preclinical CT and multimodal contrast agents. The oil can be used to formulate contrast agents in your lab and incorporate imaging probes for multimodal imaging projects.   This oil was developed in the laboratory of... Learn More

Shielding NorthStar's first pair of IBA Rhodotron® accelerators - a first-of-its-kind radioisotope facility.​ Harleysville, PA., June 27, 2022 (Newswire.com) - As part of its expansion of radiation shielding solutions in the Industrial segment for radiopharmaceutical manufacturing, Veritas Medical Solutions recently... Learn More

ABX is the leading manufacturer of high-quality radiopharmaceutical products for molecular imaging & therapy mainly used for the the detection of tumors by PET and SPECT.  Our company develops, produces, tests and markets precursors/active ingredients, reagent kits and hardware cassettes. ... Learn More

Phantech has partnered with Gremse-IT to automate the analysis of all of our standard phantoms, including our derenzo, partial volume correction, BioMouse, NEMA NU 4-2008, SPECT-IQ, and uniformity phantoms. ... Learn More

TORONTO, ON – Cancer patients in Canada and around the world will receive treatment using Yttrium-90 (Y-90) isotopes produced by Laurentis Energy Partners (Laurentis) and harvested from Ontario Power Generation’s (OPG) Darlington Nuclear Generating Station.  Ontario’s Minister of Health and Deputy Premier, Sylvia Jones and Minister of Energy, Todd Smith joined Laurentis... Learn More

United Well is a professional supplier of nuclear medicine products and services, dedicated to the management and layout of radiopharmaceuticals and their upstream and downstream industries, including the R&D, production, marketing and application of radiopharmaceuticals raw materials, medical isotopes, diagnostic and therapeutic radiopharmaceuticals, etc. We tailor the... Learn More

The Centre for Addiction and Mental Health (CAMH), Canada’s largest mental health teaching hospital and a leading research centre, has joined the Canadian Nuclear Isotope Council (CNIC). CAMH is a global leader in brain imaging. As one of few brain imaging centres in the world that is... Learn More

QDOSE® Multi-purpose Voxel Dosimetry Software (Personalized Dosimetry in Molecular Radiotherapy) received USFDA 510(k) clearance in August 2023. Developed by ABX-CRO (Dresden, Germany) in collaboration with Quantinm AB (Stockholm, Sweden), this software provides state-of-the-art assessment of radiation absorbed dose to organs and tissues of the body from medically administered radiopharmaceuticals. It... Learn More